Literature DB >> 2201513

Thyroxine-dependent modulations of the expression of the neural cell adhesion molecule N-CAM during Xenopus laevis metamorphosis.

G Levi1, F Broders, D Dunon, G M Edelman, J P Thiery.   

Abstract

During amphibian metamorphosis, a complete remodeling of the phenotype takes place under complex hormonal control whose final effectors are thyroid hormones. This process implies the activation of coordinated programs of cell death, proliferation, migration, adhesion and differentiation. Inasmuch as the neural cell adhesion molecule N-CAM is thought to play a central role in the control of morphogenetic processes, we have studied by immunohistofluorescence and immunoblots the patterns of expression of N-CAM at different stages of Xenopus laevis metamorphosis. A scan was made of all major organs and appendages. Before the metamorphic climax, all neuronal cell bodies and processes express high levels of N-CAM. During the metamorphic climax, N-CAM expression decreases sharply on the cell bodies and processes of the peripheral nervous system (PNS) but remains high in the central nervous system (CNS). Towards the end of metamorphosis, the PNS and spinal nerves are virtually negative for N-CAM while the CNS is still positive. The optic and olfactory nerves, although myelinated, are still strongly positive for N-CAM. The lens and olfactory epithelia express N-CAM throughout metamorphosis. In the brain. N-CAM is present at all times as three polypeptides of 180, 140, and 120 X 10(3) Mr; before metamorphosis some of the N-CAM is in its polysialylated form. During metamorphosis and the subsequent growth of the animal, the amount of N-CAM decreases gradually. In all polypeptides, the polysialylated form is the first to disappear. Cardiac muscle expresses high level of N-CAM from its first formation throughout metamorphosis; in contrast, the level of N-CAM in skeletal muscle is high in newly formed muscles, but decreases rapidly after myoblast fusion. The liver of adult Xenopus contains large amounts of a 160 X 10(3) polypeptide that is recognized by polyclonal and monoclonal antibodies against N-CAM. cDNA probes of Xenopus brain N-CAM recognize major transcripts of 9.2, 3.8 and 3.3 kb in Xenopus liver mRNA; these bands are different in size from those recognized in brain mRNA (9.5, 4.2 and 2.2 kb). Premetamorphic liver does not express the 160 X 10(3) form of N-CAM, which can be first detected at stage 59 and persists then through all the life of the animal. Expression of N-CAM in the liver can be induced in premetamorphic animals (stage 51-52) by a 48 h treatment with thyroxine. All hepatocytes are responsive.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2201513     DOI: 10.1242/dev.108.4.681

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  5 in total

1.  Cell adhesion molecules duringXenopus myogenesis.

Authors:  G Levi
Journal:  Cytotechnology       Date:  1993-01       Impact factor: 2.058

2.  Functions and expression of liver N-CAM.

Authors:  C Tacchetti; L Simmonneau; J P Thiery; G Levi
Journal:  Cytotechnology       Date:  1993-01       Impact factor: 2.058

3.  Distribution of NCAM-180 and polysialic acid in the developing tectum mesencephali of the frog Discoglossus pictus and the salamander Pleurodeles waltl.

Authors:  C G Becker; T Becker; G Roth
Journal:  Cell Tissue Res       Date:  1993-05       Impact factor: 5.249

4.  Thyroid hormone-dependent transcriptional repression of neural cell adhesion molecule during brain maturation.

Authors:  T Iglesias; J Caubín; H G Stunnenberg; A Zaballos; J Bernal; A Muñoz
Journal:  EMBO J       Date:  1996-08-15       Impact factor: 11.598

5.  Differential perturbations in the morphogenesis of anterior structures induced by overexpression of truncated XB- and N-cadherins in Xenopus embryos.

Authors:  S Dufour; J P Saint-Jeannet; F Broders; D Wedlich; J P Thiery
Journal:  J Cell Biol       Date:  1994-10       Impact factor: 10.539

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.